Table: Cosmos Pharmaceutical - 9-MTH group results

Cosmos Pharmaceutical

10/04/2023 07:00

Apr 10 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Feb 28, 2023        Feb 28, 2022     May 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            606.30              558.89           813.50    
                 (+8.5 pct)                           (+7.7 pct)  
  Operating         22.17               21.90            30.00    
                 (+1.2 pct)                           (+0.7 pct)  
  Recurring         24.39               24.10            33.00    
                 (+1.2 pct)                           (+0.4 pct)  
  Net               16.28               16.46            23.20    
                 (-1.0 pct)                           (+0.2 pct)  
  EPS            411.22 yen          415.56 yen       585.87 yen  
  Ann Div                             80.00 yen        85.00 yen  
  -Q2 div         42.50 yen           40.00 yen                   
  -Q4 div                             40.00 yen        42.50 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T